Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Genome × Dermatologic × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Thoracic 1 Genitourinary 1 Dermatologic 1 Breast 1

Conditions

Skin Neoplasms 1 Nevus 1 Melanoma 1 Dysplastic Nevus Syndrome 1

Interventions

pembrolizumab 298 Nivolumab 266 Ipilimumab 237 Cyclophosphamide 176 aldesleukin 135 Interleukin-2 97 fludarabine phosphate 93 trametinib 78 fludarabine 76 Dacarbazine 72 dabrafenib 69 Temozolomide 69 Radiotherapy 69 Biopsy 66 Vemurafenib 63 Radiosurgery 48 Imiquimod 48 Bevacizumab 47 Magnetic Resonance Spectroscopy 46 Blood Specimen Collection 45 sargramostim 43 Specimen Handling 43 Aminolevulinic Acid 43 3-ingenyl angelate 42 Peripheral Blood Stem Cell Transplantation 41 Cisplatin 41 Paclitaxel 40 Carboplatin 39 cemiplimab 38 atezolizumab 38

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05446155 2024-01-23

BioMEL

Region Skane

Dysplastic Nevus Syndrome, Melanoma, Nevus, Skin Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡